CyberKnife Treatment in India: A Complete Guide for Patients from Bangladesh

Author:- Dr. Dheeraj Bojwani Date Created:- 06-08-2026

What a Bangladeshi patient and their family should know before choosing a hospital, city and care team across the border — costs, process and the questions worth asking before you book a ticket. Bangladesh's radiotherapy shortage is severe enough that it regularly makes national news for the wrong reasons. Based on international benchmarks, the country needs roughly 300 radiotherapy machines to meet patient demand; recent reporting puts the actual number in public and private hospitals at around 37, many of them ageing or out of service, with the country's main cancer hospital periodically forced to halt all radiotherapy entirely when its last working machines break down. Against that backdrop, advanced robotic radiosurgery technology such as CyberKnife — used in dozens of dedicated centres across India — is not something a Bangladeshi patient can currently access at home at all, at any price. This guide sets out what CyberKnife treatment in India actually involves, what it realistically costs compared with the UK and US, and the practical decisions that separate a smooth trip from a stressful one.

Healing Journeys of Bangladeshi Patients

Bangladeshi Patients Share Their Experience

Key Takeaways

• The guide highlights the severe radiotherapy shortage in Bangladesh. Based on international benchmarks, Bangladesh needs roughly 300 radiotherapy machines, while recent reporting cited in the guide puts the actual number at around 37 machines, many ageing or out of service. CyberKnife technology is therefore not currently available to Bangladeshi patients domestically.
• CyberKnife is a form of stereotactic radiosurgery that does not involve cutting or an incision. A robotic arm delivers highly focused radiation from multiple angles while continuous imaging tracks the tumour, including targets that may move slightly with breathing.
• The treatment typically involves one to five sessions, compared with approximately 25–35 sessions for conventional fractionated radiotherapy. It is generally outpatient-based and does not typically require anaesthesia or a lengthy hospital admission.
• CyberKnife is not appropriate for every tumour. Suitability depends on the tumour's size, location and type, and the guide strongly recommends multidisciplinary tumour-board assessment before treatment. This is particularly important for tumours near critical structures, recurrent tumours or cases where conventional surgery may carry greater risk.
• The cost chart on page 3 gives an indicative 2026 range of US$4,500–10,000 in India for a complete CyberKnife treatment course, compared with US$25,000–40,000 in the UK and US$35,000–100,000+ in the US. Fiducial marker placement or combined treatment may increase the overall cost.
• The guide recommends asking Indian hospitals for an itemised quotation confirming whether planning CT/MRI, the exact number of treatment sessions, fiducial marker placement and initial follow-up imaging are included. Combined treatment involving surgery or chemotherapy is generally priced separately.
• The seven-stage journey diagram on page 4 shows remote teleconsultation and tumour-board review, cost and hospital confirmation, medical visa and travel, planning imaging and fiducial placement if required, CyberKnife sessions, recovery and initial follow-up, followed by return to Bangladesh for imaging-based monitoring. Total time away is generally around two to three weeks.

Quick Facts

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

Treatment

CyberKnife Treatment

Country

India

Patients

Bangladeshi Patients

Treatment Type

Stereotactic Radiosurgery

Key Specialist

Radiation Oncologist with CyberKnife Experience

Technology

Robotic, Image-Guided Radiosurgery

Treatment Sessions

1–5 sessions

Conventional Comparison

Conventional radiotherapy may require 25–35 sessions

Potential Uses

Tumours near critical structures, recurrent tumours and selected medically inoperable tumours

India Cost

US$4,500–10,000 for a complete treatment course

UK Cost

US$25,000–40,000

US Cost

US$35,000–100,000+

Typical Stay

Approximately 2–3 weeks

Planning

CT/MRI imaging and fiducial placement if required

Hospital Check

NABH or JCI accreditation verified directly

Key Assessment

Multidisciplinary tumour-board confirmation of CyberKnife candidacy

Medical Visa

Indian medical visa with hospital invitation

Attendants

Up to three accompanying attendants

Follow-Up

Imaging-based tumour response monitoring in Bangladesh

Key Warning

CyberKnife is not suitable for every tumour; candidacy should be confirmed by a multidisciplinary tumour board.

In Brief

CyberKnife treatment in India can provide Bangladeshi patients access to dedicated robotic radiosurgery centres, trained radiation oncology teams and multidisciplinary tumour-board assessment. The guide emphasises that CyberKnife should be recommended only after confirming that the tumour's size, location and type make it an appropriate option, rather than simply because a centre offers the technology. A complete treatment course is estimated at approximately US$4,500–10,000 in India, with one to five treatment sessions and a typical overall stay of two to three weeks, followed by imaging-based monitoring in Bangladesh.

What CyberKnife Treatment Actually Involves

CyberKnife is a form of stereotactic radiosurgery — despite the name, it involves no cutting at all. A robotic arm delivers highly focused beams of radiation to a tumour from many angles, guided by continuous imaging that tracks the tumour's exact position, including tumours that move slightly with breathing. Key features include:

• Sub-millimetre precision — allowing a high, tumour-destroying dose of radiation to be concentrated on the target while sparing surrounding healthy tissue far more than conventional radiotherapy.
• One to five treatment sessions — compared with the 25 to 35 sessions typical of conventional fractionated radiotherapy, delivered on an outpatient basis with no anaesthesia or incision.
• Suitability for tumours near critical structures — including the brain, spine, and areas close to major blood vessels or nerves — where conventional surgery carries higher risk.
• Use for recurrent or previously treated tumours, and for patients who are not good candidates for open surgery due to the tumour's location or their overall health.

CyberKnife is not the right choice for every tumour. Its suitability depends on the tumour's size, location and type, and this should be assessed by a multidisciplinary tumour board rather than assumed. Ask specifically whether CyberKnife is being recommended because it is genuinely the best option for this tumour, or simply because the treating centre offers it.

Why the National Radiotherapy Shortage Matters for Treatment Planning

Because even conventional radiotherapy capacity in Bangladesh falls so far short of international benchmarks — with waiting times reportedly stretching to eight to ten months at the country's main cancer hospital, and treatment sometimes stopping nationally when machines fail — advanced technologies like CyberKnife are simply outside what is available domestically at any price point. This has a direct planning consequence for a specific group of patients: those with tumours near critical structures, recurrent disease after prior treatment, or medically inoperable tumours, for whom CyberKnife is a genuine treatment option rather than a convenience upgrade. For these patients, the question is not "can I get faster treatment abroad" but "is this treatment available to me anywhere in my own country" — and currently, for CyberKnife specifically, the honest answer is no.

Why India Specifically for CyberKnife?

India has become the most accessible destination for Bangladeshi patients seeking CyberKnife treatment abroad. Peer-reviewed research surveying patients directly at the Indian Visa Application Centre in Chittagong found that the decision consistently comes down to a combination of experienced specialist teams, hospital quality and cost. Several practical advantages reinforce this pattern for CyberKnife specifically:

• Multiple dedicated CyberKnife centres, using the same Accuray-certified systems used globally, staffed by radiation oncologists and physicists specifically trained on the technology.
• Multidisciplinary tumour board assessment before treatment, to confirm CyberKnife is genuinely the right approach for the specific tumour rather than the only option a single centre happens to offer.
• Short, outpatient-based treatment courses, meaning most patients do not need a lengthy hospital stay, unlike surgery-based cancer treatments.
• Easy connectivity and an established medical-visa system built specifically around Bangladeshi patients, including a dedicated government portal for hospital invitation letters and provision for up to three accompanying attendants.

What the Numbers Actually Mean

The headline number matters less than what it includes. A Bangladeshi patient comparing quotes should ask each Indian hospital to confirm whether the figure covers the planning CT or MRI scan, the exact number of sessions included, fiducial marker placement if the tumour needs it for tracking, and the initial follow-up imaging after treatment. Combined treatment — CyberKnife alongside surgery or chemotherapy for more complex cases — is priced separately.

Peer-reviewed research on cross-border medical travel found that international patients spend an average of 3,800 to 7,000 US dollars per visit once transport, accommodation and incidental costs are added to treatment itself — a range worth budgeting for on top of the treatment cost shown above. CyberKnife involves a notably shorter stay than most cancer treatments covered in this series: realistically, 10 to 20 days in India covers planning, all sessions, and an initial recovery check, since no hospital admission or lengthy isolation is typically required.

Most Bangladeshi patients follow a broadly similar sequence, whether they travel independently or through a medical-facilitation service. Knowing the shape of it in advance makes each step easier to plan for.

Factors a Bangladeshi Patient Should Weigh Before CyberKnife Treatment in India

Beyond the treatment itself, the decisions that most affect a patient's experience are logistical and financial rather than purely medical. Consider each of the following before confirming a hospital:

• Which city, not just which hospital. Kolkata is closest and most familiar linguistically; Chennai, Delhi and Mumbai often have a wider choice of dedicated CyberKnife centres. Weigh travel time and cost against the specific centre's experience with this exact tumour type.
• Genuine multidisciplinary confirmation of candidacy — not the recommendation of a single CyberKnife centre alone. Ask whether a tumour board including a surgeon and medical oncologist agrees this is the right approach.
• The centre's case volume with this specific tumour type using CyberKnife, since experience varies by tumour site.
• Genuine hospital accreditation. Ask whether the hospital holds NABH or JCI accreditation and verify it directly through the accreditation board's own directory rather than taking a brochure's word for it.
• An itemised, written estimate covering planning imaging, the exact number of sessions, and any fiducial marker placement or additional procedures.
• Medical visa documentation. A formal invitation letter from the treating hospital, submitted through India's official medical-visa channel, is required at the Indian visa centre in Dhaka, Chittagong, Sylhet or Rajshahi.
• A travel companion. Indian hospitals generally expect at least one attendant to stay with the patient; factor their stay, food and local transport into the budget.
• A written follow-up imaging plan for after you return, since confirming the tumour has responded to treatment takes months, not days, and needs a doctor in Bangladesh to coordinate.

Before You Book: A Checklist for CyberKnife Treatment in India

A Closing Words

For Bangladeshi patients whose tumours are genuinely suited to it, India offers something not currently available at home at any price: robotic radiosurgery technology delivered by experienced, dedicated teams, at a fraction of the cost charged in the UK or US. The value, however, depends entirely on the specifics: honest, multidisciplinary confirmation that CyberKnife is the right treatment for this particular tumour, a transparent itemised estimate, and a realistic plan for follow-up imaging back home. Patients who ask detailed questions before booking, rather than after arriving, consistently report a smoother experience — medically and financially.

Sources

• 🌐 National Medical Commission of India — statutory body for verifying a doctor's registration and specialist qualifications. · nmc.org.in
• 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) — India's principal healthcare accreditation authority, under the Quality Council of India. · nabh.co
• 🌐 Cancer Control in Bangladesh. Peer-reviewed review, hosted via NIH/NCBI, quantifying Bangladesh's radiotherapy machine shortfall against international benchmarks. · pmc.ncbi.nlm.nih.gov/articles/PMC3842101
• 🌐 Determinants of Bangladeshi patients' decision-making process and satisfaction toward medical tourism in India. Peer-reviewed study, hosted via NIH/NCBI. · pmc.ncbi.nlm.nih.gov/articles/PMC10185743
• 🌐 Government of India — Medical Value Travel / e-Medical Visa Portal, Bureau of Immigration, Ministry of Home Affairs — official channel for hospital invitation letters and medical-visa provisions for Bangladeshi nationals. · indianfrro.gov.in/frro/medicalvaluetravel

Frequently Asked Questions by Bangladeshi Patients about CyberKnife Treatment in India

Is CyberKnife treatment available in Bangladesh for Bangladeshi patients?

The guide states that CyberKnife is currently not available domestically in Bangladesh, against a broader shortage of radiotherapy capacity. India therefore provides access to this technology for appropriately selected patients.

How does CyberKnife differ from conventional radiotherapy for Bangladeshi patients?

CyberKnife delivers highly focused radiation in one to five sessions, while conventional fractionated radiotherapy commonly requires around 25–35 sessions. CyberKnife is also outpatient-based and involves no surgical incision.

How does a Bangladeshi patient know if CyberKnife is suitable for their tumour?

Suitability depends on the tumour's size, location and type. The guide recommends multidisciplinary tumour-board assessment using the patient's imaging rather than relying only on a CyberKnife centre's recommendation.

Can CyberKnife be considered for recurrent cancer in Bangladeshi patients?

It can be considered for selected recurrent or previously treated tumours, particularly where conventional surgery may be difficult. However, the patient's individual imaging and treatment history must be reviewed before deciding.

How much does CyberKnife treatment cost in India for Bangladeshi patients?

The page 3 cost chart gives an indicative range of US$4,500–10,000 for a complete CyberKnife treatment course in India. Fiducial marker placement or combined treatment can increase the final cost.

What should a Bangladeshi patient check in a CyberKnife quotation?

Ask whether the estimate includes planning CT/MRI, the exact number of sessions, fiducial markers if needed and initial follow-up imaging. Surgery or chemotherapy provided alongside CyberKnife may be billed separately.

How long does a Bangladeshi patient need to stay in India for CyberKnife?

Most patients should plan for approximately two to three weeks, including planning, treatment sessions and an initial recovery or follow-up check. The actual duration depends on the tumour and treatment plan.

Do Bangladeshi patients need a medical visa for CyberKnife treatment in India?

Yes. The guide states that patients need a medical visa supported by an invitation letter from the treating Indian hospital, with a medical-attendant visa available for accompanying family members.

Can follow-up after CyberKnife in India continue in Bangladesh?

Yes. Follow-up imaging is expected to continue for months after treatment to assess tumour response. The Indian team should provide a clear imaging and follow-up plan that can be coordinated with a doctor in Bangladesh.

What is the most important question Bangladeshi patients should ask before choosing CyberKnife in India?

Ask whether an independent multidisciplinary tumour board has confirmed that CyberKnife is genuinely the best treatment for the specific tumour. The guide cautions against choosing CyberKnife simply because a particular centre offers it.

Page Summary

The seven-page guide explains CyberKnife treatment in India for Bangladeshi patients, focusing on the country's major radiotherapy capacity shortage and the availability of advanced robotic radiosurgery in India. It explains how CyberKnife differs from conventional radiotherapy, when it may be considered, why tumour-board assessment is essential, and what patients should check regarding cost, hospital credentials and follow-up. The page 3 cost chart places a complete CyberKnife course at US$4,500–10,000 in India, while the page 4 journey diagram presents a seven-stage pathway requiring approximately two to three weeks away from Bangladesh.

Citation Block

Field	Information
Article / Topic	CyberKnife Treatment in India for Patients from Bangladesh
Treatment	CyberKnife / Stereotactic Radiosurgery
Country / Patients	India / Bangladeshi Patients
Key Specialist	Radiation Oncologist with CyberKnife Experience
Technology	Robotic, image-guided radiosurgery with sub-millimetre precision
Treatment Sessions	1–5 outpatient sessions
Conventional Radiotherapy	Typically 25–35 sessions
Potential Candidates	Selected tumours near critical structures, recurrent tumours and medically inoperable cases
Candidacy Assessment	Multidisciplinary tumour-board review based on tumour size, location and type
Tumour Sites	Brain, spine and areas close to major blood vessels or nerves may be considered
Planning	CT/MRI planning and fiducial marker placement when required
India Cost	US$4,500–10,000 for a complete CyberKnife treatment course
UK Cost	US$25,000–40,000
US Cost	US$35,000–100,000+
Typical Stay	Approximately 2–3 weeks in India
Hospital Requirements	Dedicated CyberKnife expertise and verified NABH or JCI accreditation
Centre Experience	Check the centre's case volume for the specific tumour type
Medical Visa	Medical visa supported by an invitation from the treating Indian hospital
Attendants	Up to three accompanying attendants for Bangladeshi patients
Cost Verification	Confirm planning scans, number of sessions, fiducial markers and initial follow-up imaging
Follow-Up	Imaging-based monitoring continues for months after treatment
Insurance	Confirm overseas treatment coverage in writing before travelling
Key Selection Criteria	Tumour-board confirmation, tumour-specific experience, hospital accreditation, transparent costing and follow-up planning
Important Warning	CyberKnife should not be recommended simply because a centre offers the technology; suitability should be independently assessed